Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Consejo Superior de Deportes, Spain | OTHER |
Not provided
Not provided
Not provided
Not provided
Post-Infectious Bronchiolitis Obliterans (PIBO) is an irreversible obstructive lung disease characterized by subepithelial inflammation and fibrotic narrowing of the bronchioles after lower respiratory tract infection. This disease is diagnosed mainly in children, more frequently before the age of 2 years. Due to symptoms such as dry cough and dyspnea sensation, most of these patients have low levels of physical activity compared to healthy individuals. Physical activity can positively influence oxygen consumption, muscle strength, and quality of life. High levels of oxygen consumption are associated with a lower risk of respiratory disease and hospitalization. High-intensity interval training (HIIT) may be an effective way to improve oxygen consumption, muscle strength, and quality of life in patients with chronic diseases. HIIT has been shown to produce less dyspnea sensation and to be more entertaining in children and adolescents with respiratory disease compared to continuous training. Thus, the investigators propose to perform telematically real-time guided training to reduce travel times and additional costs to patients.
Objective: To analyze the effects of a telematically supervised high-intensity intervallic training program on aerobic fitness, as well as functional/clinical outcomes in patients with PIBO.
Methods: Randomized controlled trial with two groups. Exercise group: 16-week HIIT training conducted telematically; Control group: will follow the routine physician's recommendations. Patients will be recruited at Vall D'Hebrón University Hospital (Barcelona), Niño Jesús University Hospital (Madrid), and Donostia Universitary Hospital (San Sebastián). Criteria for participation: (I) Diagnosis of PIBO; (II) Clinically stable at the time of the assessments; (III) Age between 6 to 20 years old.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Exercise group | Experimental | 16 weeks of a "High Intensity Interval Training" exercise program conducted telematically with real time supervision twice a week. The exercise program consists of a circuit of exercises aiming to achieve a target heart rate for each fitness level. |
|
| Control group | No Intervention | Routine physician recommendations for physical activity. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Exercise group | Other | Participants will perform a 16-week High Intensity Interval Training exercise program, twice a week. The intervention will be conducted telematically with real time supervision. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in peak oxygen consumption | Change in peak oxygen consumption (mL/kg/min) will be evaluated through cardiopulmonary exercise testing (CPET). | Change from baseline to 16 weeks |
| Change in time to ventilatory threshold | Change in time to ventilatory threshold (minutes) will be evaluated through cardiopulmonary exercise testing (CPET). | Change from baseline to 16 weeks |
| Change in percent oxygen consumption at ventilatory threshold | Change in percent oxygen consumption at ventilatory threshold will be evaluated through cardiopulmonary exercise testing (CPET). | Change from baseline to 16 weeks |
| Change in ventilatory efficiency | Change in ventilatory efficiency will be evaluated by combining ventilation (VE) and carbon dioxide production (VCO2) measurements to report VE/VCO2 ratio, evaluated through cardiopulmonary exercise testing (CPET). | Change from baseline to 16 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Change in forced expiratory volume in the first second | Change in forced expiratory volume in the first second (liters) will be evaluated through spirometry. | Change from baseline to 16 weeks |
| Change in forced vital capacity |
| Measure | Description | Time Frame |
|---|---|---|
| Height in meters | Height will be evaluated using a stadiometer. | Change from baseline to 16 weeks |
| Weight in kilograms | Weight will be evaluated using a weight scale. |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Márcio VF Donadio, PhD | Universitat Internacional de Catalunya | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Universitario Donostia | Donostia / San Sebastian | Basque Country | 20014 | Spain | ||
| Hospital Universitari Vall d'Hebron |
The investigators will collect patients' personal data and clinical history by means of the information delivered by the participating hospital. These data will be stored and coded in an Excel file in order to protect confidentiality before, during and after the study. All information will be entered and stored electronically in the institutional platform REDCAP hosted on the hospitals' server.
Not provided
After completion of study, the data will be stored for as long as necessary to meet any possible responsibilities derived from the study.
Access will be given only to the researchers of the study.
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| ICF | No | No | Yes | Informed Consent Form | Mar 21, 2023 | May 25, 2023 | ICF_000.pdf |
Not provided
| ID | Term |
|---|---|
| D001989 | Bronchiolitis Obliterans |
| ID | Term |
|---|---|
| D001988 | Bronchiolitis |
| D001991 | Bronchitis |
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000072696 | High-Intensity Interval Training |
| ID | Term |
|---|---|
| D064797 | Physical Conditioning, Human |
| D015444 | Exercise |
| D009043 | Motor Activity |
| D009068 | Movement |
Not provided
Not provided
Multicenter study, randomized controlled trial in two parallel groups (ratio 1:1), double blinded.
Not provided
Not provided
The evaluators and care providers will be masked to the allocation of the patients. Given the nature of the intervention, it is not possible to mask patients or monitors in charge of supervising the execution of the exercise training.
|
Change in forced vital capacity (liters) will be evaluated through spirometry.
| Change from baseline to 16 weeks |
| Change in forced expiratory flow between 25 and 75% of forced vital capacity | Change in forced expiratory flow between 25 and 75% of forced vital capacity (liters/minute) will be evaluated through spirometry. | Change from baseline to 16 weeks |
| Change in muscle strength | Changes in muscle strength will be evaluated using a dynamometer. | Change from baseline to 16 weeks |
| Change in lower body strength | Changes in lower body strength will be evaluated using the 30 seconds Sit to Stand Test (30STS). | Change from baseline to 16 weeks |
| Change in free fat mass | Changes in free fat mass (percent) will be evaluated through bioimpedance. | Change from baseline to 16 weeks |
| Change in lean mass | Changes in lean mass (percent) will be evaluated through bioimpedance. | Change from baseline to 16 weeks |
| Change in hip-waist ratio | Changes in hip-waist ratio will be evaluated by combining hip circumference and waist circumference measurements using a non-stretchable tape measure. | Change from baseline to 16 weeks |
| Change in body mass index | Changes in body mass index will be evaluated by combining weight and height measurements to report BMI (kg/m^2). | Change from baseline to 16 weeks |
| Change in quality of life | Changes in quality of life will be evaluated through the Saint George's Respiratory Questionnaire (SRQ). The overall result of the scale is a numerical value from 0 to 100, with the highest values corresponding to a worse quality of life. | Change from baseline to 16 weeks |
| Change in dyspnea | Changes in dyspnea will be evaluated through the Medical Research Council (mMRC) modified dyspnea scale. The overall result of the scale is a numerical value from 0 to 4, where the highest value corresponds to the worse dyspnea. | Change from baseline to 16 weeks |
| Change from baseline to 16 weeks |
| Daily physical activity level | Daily physical activity level will be evaluated through the physical activity questionnaire (PAQ). The overall test score is from 1 to 5 points, with a higher score indicating a higher level of activity. | Change from baseline to 16 weeks |
| Barcelona |
| Catalonia |
| 08035 |
| Spain |
| Hospital Universitario Infantil Niño Jesús | Madrid | 28009 | Spain |
| D008173 |
| Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D009142 |
| Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |